Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-17

Clinical Trial Update: Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function [NA]

View source ↗

Summary

This clinical trial update reports on the feasibility of the AccuCinch system to reshape the left ventricle and reduce functional mitral regurgitation in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ancora Heart, Inc. | Conditions: Severe Functional Mitral Regurgitation and Heart Failure | NA | Status: COMPLETED